RSS

Helsinn

Here, we reveal some of the news, developments and product innovations that have been released from the show floor of day 1 of this year’s CPhI Worldwide congress in Frankfurt more

News

Swiss pharmaceutical group, Helsinn, has opened an office in Shanghai, China, as part of the group’s commitment to the region — Helsinn Pharmaceuticals (Beijing). more

News

Swiss-based pharma group Helsinn has revealed its US subsidiary (Helsinn Therapeutics) has signed a co-promotion agreement with Novartis for Zykadia more

News

Helsinn’s anamorelin HCI has been accepted for marketing authorisation application (MAA) review by the European Medicines Agency (EMA) more

News